Home›People›Michael Sadowsky
Michael Sadowsky

Michael Sadowsky

Chief manufacturing and operations officer at Gut-Brain-Axis Therapeutics

Director
Updated Nov 4, 2026·Latest SEC filing Oct 27, 2026·Suggest an edit

About Michael Sadowsky

Michael Sadowsky is chief manufacturing and operations officer of Gut-Brain-Axis Therapeutics, which is developing a gut bacteria transplant for autism and Pitt-Hopkins syndrome. He is also one of its directors. His lab at the University of Minnesota helped develop and standardize the donor bacteria therapy the company is building. He is a Distinguished McKnight University Professor Emeritus in the university's Department of Soil, Water, and Climate. He is a former director of the university's BioTechnology Institute, a post he held for 13 years.

Before that he was co-director of the university's Microbial and Plant Genomics Institute. In November 2018, TerraMax, a maker of bacteria-based products for crops, announced that he had joined its 2019 board of directors. He became a Distinguished McKnight University Professor in 2004, and he holds a PhD in microbiology from the University of Hawaii.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Michael Sadowsky in the role, so the role may have started earlier or lasted longer.

Gut-Brain-Axis Therapeutics Inc. Current
Chief Manufacturing and Operations Officer, director
2023 – Present · Tempe, AZ
Develops a treatment that replaces harmful gut bacteria with healthy donor bacteria, aimed at autism and Pitt-Hopkins syndrome.
University of Minnesota Current
Distinguished McKnight University Professor Emeritus
Director, BioTechnology Institute
Co-Director, Microbial and Plant Genomics Institute
TerraMax, Inc.
Board member

Key Colleagues at Startups

The people Michael Sadowsky works with at each company, as listed on that company's latest Form D.

Gut-Brain-Axis Therapeutics Inc. · Form D/A, Oct 27, 2026
James Adams
James Adams
President and Chief Executive Officer, director
Alexander Khoruts
Alexander Khoruts
Chief Medical Officer and director
Rosa Krajmalnik-Brown
Rosa Krajmalnik-Brown
Chief Science Officer and director

Michael Sadowsky in the News

Sources

  1. SECGut-Brain-Axis Therapeutics Inc. Form D/A, filed Oct 27, 2026
  2. University siteStaff & Faculty, University of Minnesota Microbiota Therapeutics Program